التفاصيل البيبلوغرافية
| العنوان: |
Lymphangioleiomyomatosis. |
| المؤلفون: |
Xu, Kai-Feng, Xu, Wenshuai, Liu, Song, Yu, Jane, Tian, Xinlun, Yang, Yanli, Wang, Shao-Ting, Zhang, Weihong, Feng, Ruie, Zhang, Tengyue |
| المصدر: |
Seminars in Respiratory & Critical Care Medicine; 2020, Vol. 41 Issue 2, p256-268, 13p |
| مصطلحات موضوعية: |
SEX hormones, TUBEROUS sclerosis, MTOR inhibitors, RAPAMYCIN, RARE diseases |
| مصطلحات جغرافية: |
UNITED States |
| مستخلص: |
Lymphangioleiomyomatosis (LAM) is a slow albeit progressive rare neoplastic disease featured with diffuse thin-walled cysts in lungs and angiomyolipomas in kidneys. LAM affects almost exclusively women and has one of the strongest gender predispositions of any extragenital human disease. Two forms of LAM present clinically, sporadic (S-LAM) and tuberous sclerosis complex-associated (TSC-LAM). TSC is an autosomal dominant genetic multisystems neoplastic disease. A high prevalence of LAM can be detected in adult female TSC patients. Tremendous progress has been made in our understanding and management of this rare disease. Both LAM and TSC are TSC2 or TSC1 mutated diseases that result in overactivation of the mechanistic target of rapamycin (mTOR) pathway. Sirolimus, an mTOR inhibitor, has been approved for LAM treatment in the United States and many other countries. Therapies targeting female sex hormones have shown preclinical efficacy in animal and cell culture-based experiments, but have not been properly investigated clinically. In this review, we summarize current recommendations in the diagnosis and treatment of LAM. [ABSTRACT FROM AUTHOR] |
|
Copyright of Seminars in Respiratory & Critical Care Medicine is the property of Thieme Medical Publishing Inc. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
